vTv Therapeutics (VTVT) Accumulated Depreciation (2014 - 2021)

vTv Therapeutics (VTVT) has 8 years of Accumulated Depreciation data on file, last reported at $305000.0 in Q4 2021.

• For the quarter ending Q4 2021, Accumulated Depreciation rose 41.2% year-over-year to $305000.0; the trailing twelve-month figure through Dec 2021 stood at $305000.0 (up 41.2% YoY), and the FY2021 full-year result was $305000.0, up 41.2% from the prior year.
• Accumulated Depreciation grew to $305000.0 in Q4 2021, from $216000.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $9.1 million in Q4 2017 to a low of $148000.0 in Q4 2019.
• A 5-year average of $3.6 million and a median of $305000.0 in 2021 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation sank 98.24% in 2019 and surged 45.95% in 2020, its largest moves.
• Tracing VTVT's Accumulated Depreciation over 5 years: stood at $9.1 million in 2017, then retreated by 7.51% to $8.4 million in 2018, then slumped by 98.24% to $148000.0 in 2019, then soared by 45.95% to $216000.0 in 2020, then soared by 41.2% to $305000.0 in 2021.
• Business Quant data shows VTVT's Accumulated Depreciation at $305000.0 in Q4 2021, $216000.0 in Q4 2020, and $148000.0 in Q4 2019.